91 filings
8-K
QSAM
QSAM Biosciences, Inc.
2 May 24
Completion of Acquisition or Disposition of Assets
10:50am
8-K
QSAM
QSAM Biosciences, Inc.
2 May 24
Amendments to Articles of Incorporation or Bylaws
8:53am
8-K
QSAM
QSAM Biosciences, Inc.
7 Feb 24
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
9:56pm
8-K
QSAM
QSAM Biosciences, Inc.
16 Jan 24
Other Events
5:08pm
8-K
QSAM
QSAM Biosciences, Inc.
14 Nov 23
Receives $2 Million Pre-Closing Collaboration and Option Fee
12:00am
8-K
5fdqxi
29 Sep 23
Unregistered Sales of Equity Securities
4:51pm
8-K
d0t k7up6
16 Aug 23
QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
4:00pm
8-K
s0obmzhmt hl
23 Jun 23
Unregistered Sales of Equity Securities
4:30pm
8-K
0xtt22wh 3ob22y30
12 May 23
Changes in Registrant's Certifying Accountant
4:30pm
8-K
wxnndf29
11 Apr 23
Regulation FD Disclosure
8:00am
8-K
kbgasl4kom6fm 6be2jn
4 Apr 23
Unregistered Sales of Equity Securities
5:00pm
8-K
0xp gtmxmkg2n
22 Mar 23
Regulation FD Disclosure
4:00pm
8-K
gud 6iq0kc7klhz9f1
25 Jan 23
Regulation FD Disclosure
10:15am
8-K
g4d xsfbg
10 Jan 23
QSAM Biosciences Provides 2022 Update and 2023 Milestones to Shareholders
4:30pm
8-K
ls40ttsw26
18 Nov 22
Unregistered Sales of Equity Securities
8:00am
8-K
rsgpehigp6bpgtbzg
15 Nov 22
QSAM Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8:30am
8-K
k4p3scv
6 Oct 22
Unregistered Sales of Equity Securities
5:05pm
8-K
oozhtv45ra2q d7v
16 Aug 22
QSAM Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
9:00am
8-K
oto7bsa4130srfztzwc
17 May 22
QSAM Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
9:00am
8-K
n7u n4xj2
9 Mar 22
Amendments to Articles of Incorporation or Bylaws
5:00pm